Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

African malaria comes to town

First, the bad news: urban malaria in Africa is becoming a major health problem and looks set to get worse.

17 Mar 2005

Fundamental mechanisms that may facilitate the design of safer and more efficacious topical drug delivery systems

In a paper published in the Proceedings of the National Academy of Sciences, a group of researchers led by Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, reports the identification of fundamental mechanisms that may facilitate the design of safer and more efficacious topical drug delivery systems.

16 Mar 2005

Nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009

According to a new report by NanoMarkets, an industry consultancy based here, nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009 and grow to $2.5 billion in 2012.

8 Mar 2005

Future out-licensing of BioSilicon in tissue engineering and orthopedics

Global nanotechnology company pSivida Limited has announced that it has signed an agreement with US based PureTech Development LLC to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.

28 Feb 2005

Medical House signs 10 year license and supply agreement with BioPartners GmbH

The Medical House, orthopaedic devices and drug delivery company and BioPartners GmbH the global biopharmaceuticals company are pleased to announce a 10 year agreement for license and supply of The Medical House's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners’ human growth hormone product, Valtropin.

22 Feb 2005

Testosterone spray improves younger women's sexual enjoyment and satisfaction

Improved sexual satisfaction for women could be just a spray on the skin away, according to the results of clinical trials led by a Monash University research team.

10 Feb 2005

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.

8 Feb 2005

Superbowl molecule shows promise for precision drug delivery

In a development that could one day score a touchdown for better health, chemists in Australia have created a "superbowl" molecule that shows promise for precision drug delivery, according to a recent study in the Journal of the American Chemical Society.

31 Jan 2005

FDA knocks back anticancer drug Marqibo

Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.

19 Jan 2005

Prototype needle-free drug and vaccine delivery device

Dr Mark Kendall, an Oxford University Research Lecturer in Engineering and Associate Director of the PowderJect Centre for Gene and Drug Delivery Research, has been named one of the top younger engineers in the country for his research into needle-free vaccine delivery technology.

17 Jan 2005

Gold is rewriting the script

Pen strokes of the rich and famous and remote-controlled drug delivery systems of the future have been given the golden treatment in a new technology being developed at the University of Melbourne.

11 Jan 2005

Serono announces the availability of Saizen for adult growth hormone deficiency

Serono announced today the availability of Saizen [somatropin (rDNA origin) for injection] for use in the treatment of patients with adult growth hormone deficiency (AGHD), following its FDA approval.

10 Jan 2005

New protein discovered holds promise for use in medicine and nanoscience

Researchers at the Hebrew University of Jerusalem have succeeded in discovering and isolating a new protein from the poplar tree with special structural and qualitative characteristics that could have consequences for development of future nanocapsules for drug delivery to cancer cells.

5 Jan 2005

FDA approval of cream to treat bacterial vaginosis

KV Pharmaceutical Company has announced that it has received approval from the United States Food and Drug Administration (FDA) to market Clindesse (clindamycin phosphate) Vaginal Cream, 2%, a single-dose prescription cream therapy indicated to treat bacterial vaginosis ("BV").

3 Dec 2004

Astronaut's eyes may become windows on the bloodstream

Our eyes may become more than windows of the soul if a multidisciplinary team of University of Michigan researchers succeeds with a clever combination of nanoparticles and ultrafast pulsed laser to see individual cells as they zip past in the bloodstream.

29 Nov 2004

Cellular vehicle delivers drugs directly into cancer cells

Researchers at The University of Texas M. D. Anderson Cancer Center have perfected a delivery system for anticancer treatment that zeroes in on a tumor and becomes part of its supporting tissue.

4 Nov 2004

Drug-loaded contact lenses to treat eye diseases

When a person suffers from eye ailments today, nine times out of ten, he will be prescribed eye drops to treat his illness or relieve his discomfort.

29 Oct 2004

Mail-order prescriptions exposed to excessive heat may become significantly less effective for patients

Mail-order prescriptions exposed to excessive environmental heat, such as temperatures found in mailboxes and car interiors, may become significantly less effective for patients.

28 Oct 2004

National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer

The Case Comprehensive Cancer Center, which includes The Cleveland Clinic Taussig Cancer Center and the Ireland Cancer Center at University Hospitals of Cleveland, will sponsor a National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer.

25 Oct 2004

PA Consulting sells drug delivery venture, Meridica, to Pfizer

Pfizer and PA Consulting Group have announced the signing of a transaction in which Pfizer will purchase the remaining 90% ownership of Meridica Limited

23 Sep 2004